Skip to main navigation Skip to search Skip to main content

Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents

  • Iwao Ojima
  • , Christopher P. Borella
  • , Xinyuan Wu
  • , Pierre Yves Bounaud
  • , Cecilia Fumero Oderda
  • , Matthew Sturm
  • , Michael L. Miller
  • , Subrata Chakravarty
  • , Jin Chen
  • , Qing Huang
  • , Paula Pera
  • , Tracy A. Brooks
  • , Maria R. Baer
  • , Ralph J. Bernacki
  • Stony Brook University
  • Roswell Park Cancer Institute

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Abstract

A series of novel taxane-based multidrug resistance (MDR) reversal agents (TRAs) has been designed and synthesized. Structure - activity relationship (SAR) study clearly indicates that modification of the C-7 position with hydrophobic arenecarbonylcinnamoyl groups brings about high potency against drug efflux mediated by P-glycoprotein (P-gp). Six TRAs exhibit ability to modulate a wide range of ATP-binding cassette (ABC) transporters, such as P-gp, multidrug resistance-associated protein 1 (MRP1), and breast cancer resistance protein (BCRP), which may serve as novel broad-spectrum modulators of ABC transporters.

Original languageEnglish
Pages (from-to)2218-2228
Number of pages11
JournalJournal of Medicinal Chemistry
Volume48
Issue number6
DOIs
StatePublished - Mar 24 2005

Fingerprint

Dive into the research topics of 'Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents'. Together they form a unique fingerprint.

Cite this